Amcor plc (ASX: AMC) reported its fourth-quarter and FY2026 results on 12 August 2026, revealing a sharp expansion in earnings and revenue following the Berry Global combination. FY2026 net sales climbed 57% to US$23.51 billion, while net income more than doubled to US$1.11 billion. Adjusted EBITDA surged 68% to US$3.67 billion, highlighting the scale of the transformed packaging group.Highlights:

• FY26 sales jumped 57%, but acquisition benefits drove much of the expansion.
• Adjusted EBITDA surged 68% as Berry synergies strengthened the earnings profile.
• Amcor now targets US$1.80–US$1.90 adjusted EPS for its transition period.

Berry Reshapes EarningsThe Berry acquisition was the dominant force behind Amcor’s FY26 performance. Of the US$23.51 billion in annual sales, approximately US$7.9 billion came from acquired sales net of divestitures. Adjusted EBIT rose 63% to US$2.81 billion, aided by roughly US$240 million of Berry-related synergies, although lower volumes partly offset the improvement.

Fourth-quarter trends offered further evidence of operational progress. Net sales increased 26% to US$6.40 billion, while adjusted EBITDA advanced 32% to US$1.05 billion. Comparable combined volumes, excluding non-core and divested operations, edged approximately 0.5% higher.Cash Flow StrengthensCash generation also improved materially, supporting Amcor as it works through integration and elevated debt.

• FY26 free cash flow increased 41% to US$1.30 billion.
• Operating cash flow reached US$2.15 billion.
• Net debt stood at US$12.90 billion at 30 June 2026.

Amcor also declared a quarterly dividend of US$0.65 per share, equivalent to AU$0.92 per CDI for ASX holders. The distribution is unfranked and scheduled for payment on 24 September 2026.Outlook Tests ExecutionAmcor is shifting to a December year-end, creating a six-month transition period through 31 December 2026. Management expects adjusted diluted EPS of US$1.80–US$1.90 and year-end leverage of 3.5–3.6 times.

The focus now shifts from acquisition-led expansion to delivering stronger operational performance and executing strategic priorities effectively. Sustaining volume momentum, capturing further Berry synergies and reducing leverage could determine whether FY26 marks the beginning of durable earnings growth rather than simply a step-change from consolidation.Note- All data presented is based on information available at the time of writing.Disclaimer for Kapitales ResearchThe materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise. 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au